Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review-Reference-Cited by-同舟云学术

Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review

Published:2013-10-21 Issue:10 Volume:8 Page:e77901
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Rui Yuan-Yi,Zhang Dan,Zhou Zong-Guang,Wang Cun,Yang Lie,Yu Yong-Yang,Chen Hai-Ning

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Global cancer statistics;A Jemal;CA Cancer J Clin,2011

2. Cancer statistics, 2013;R Siegel;CA Cancer J Clin,2013

3. Estimation and projection of the national profile of cancer mortality in China: 1991-2005;L Yang;Br J Cancer,2004

4. Clinical practice guidelines in oncology: colon cancer,2013

5. Clinical practice guidelines in oncology: rectal cancer,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KRAS and BRAF Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient Cohort;International Journal of Molecular Sciences;2023-12-15

2. Predictive factors of survival of colorectal cancer patients after para-aortic lymph node metastasis;International Journal of Clinical Oncology;2021-11-27

3. Overexpression of DJ-1 enhances colorectal cancer cell proliferation through the cyclin-D1/MDM2-p53 signaling pathway;BioScience Trends;2020-04-30

4. Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy;Współczesna Onkologia;2020

5. Molecular characteristics of colorectal cancer in a Middle Eastern population in a single institution;Annals of Saudi Medicine;2018-07